Enara Bio
enarabio.comLocations
England, UK · London, UK · Oxford, UK
industry
Biotechnology
Size
51 - 200 employees
Stage
Other
founded in
2016
Enara Bio is a science-led company targeting the T-cell/cancer cell interface (the “immune synapse”) to develop new targeted cancer immunotherapies designed to treat a broad patient population. Enara Bio focuses on discovering and developing therapeutic cancer vaccines utilizing novel antigens derived from Endogenous Retroviral (ERV)-related DNA sequences.
Something looks off?Open jobs at Enara Bio
On-site & Remote
Seniority
Salary